Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Melero

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Immuno-Oncology Technology|July 26, 2024
Regional and intratumoral adoptive T-cell therapyI Olivera, I Etxeberria, C Luri-Rey, et al.
Atencion Primaria|February 7, 1998
[The evaluation of a self-measurement arterial pressure monitor: the OMRON-HM 722C]R Córdoba, M I Fuertes, A Alvarez, et al.
Chemical Immunology|January 1, 1996
Functional resemblance between the Ig-related NK cell receptors specific for HLA class I molecules and the CD94 C-type lectinM López-Botet, J J Pérez-Villar, M Carretero, et al.
Cellular Immunology|January 8, 1999
NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodiesI Melero, J V Johnston, W W Shufford, et al.
European Journal of Immunology|September 1, 1996
Functional analysis of alpha 1 beta 1 integrin in human natural killer cellsJ J Pérez-Villar, I Melero, A Gismondi, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 6, 2002
Gene therapy of primary and metastatic liver tumorsJ Prieto, C Qian, I Melero, et al.
Gut|March 26, 2003
The promise of gene therapy in gastrointestinal and liver diseasesJ Prieto, M Herraiz, B Sangro, et al.
European Journal of Immunology|April 29, 1998
Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathwayI Melero, N Bach, K E Hellström, et al.
Gut|January 5, 2002
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignanciesV Schmitz, C Qian, J Ruiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergyI Narvaiza, G Mazzolini, M Barajas, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Immuno-Oncology Technology|July 26, 2024
Regional and intratumoral adoptive T-cell therapyI Olivera, I Etxeberria, C Luri-Rey, et al.
Atencion Primaria|February 7, 1998
[The evaluation of a self-measurement arterial pressure monitor: the OMRON-HM 722C]R Córdoba, M I Fuertes, A Alvarez, et al.
Chemical Immunology|January 1, 1996
Functional resemblance between the Ig-related NK cell receptors specific for HLA class I molecules and the CD94 C-type lectinM López-Botet, J J Pérez-Villar, M Carretero, et al.
Cellular Immunology|January 8, 1999
NK1.1 cells express 4-1BB (CDw137) costimulatory molecule and are required for tumor immunity elicited by anti-4-1BB monoclonal antibodiesI Melero, J V Johnston, W W Shufford, et al.
European Journal of Immunology|September 1, 1996
Functional analysis of alpha 1 beta 1 integrin in human natural killer cellsJ J Pérez-Villar, I Melero, A Gismondi, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|September 6, 2002
Gene therapy of primary and metastatic liver tumorsJ Prieto, C Qian, I Melero, et al.
Gut|March 26, 2003
The promise of gene therapy in gastrointestinal and liver diseasesJ Prieto, M Herraiz, B Sangro, et al.
European Journal of Immunology|April 29, 1998
Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathwayI Melero, N Bach, K E Hellström, et al.
Gut|January 5, 2002
Gene therapy for liver diseases: recent strategies for treatment of viral hepatitis and liver malignanciesV Schmitz, C Qian, J Ruiz, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2000
Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergyI Narvaiza, G Mazzolini, M Barajas, et al.
Pageof 7